Hide filtersShow filters × Close Bryan, Garnier & Co. successfully completes the placement of the international tranche of Arkimedica’s € 28 million convertible bond Bryan, Garnier & Co advised Plethico Pharmaceuticals Limited on its acquisition of Natrol, Inc. Bryan, Garnier & Co successfully leads a €40 million private placement in public equity for BioAlliance Bryan, Garnier & Co successfully leads a €100.1 million capital increase for Transgene Bryan, Garnier & Co successfully leads a €33.7 million IPO for Innate Pharma Bryan, Garnier & Co leads a 11,5 million IPO for MEDICREA on Alternext Bryan, Garnier & Co & ING announce the successful completion of BioAlliance Pharma (Eurolist Paris : FR0010095596) EUR 30 m Initial Public Offering Bryan, Garnier & Co, the European Growth investment bank successfully led the the secondary placement of a EUR 13M holding of 21 Investimenti in Stedim, a Euronext-listed company Bryan, Garnier & Co Leads a EUR 34,9 M follow-on offering of Ordinary Shares with Warrants (ABSA) from Leading International Institutional Investors for Transgene (Eurolist Paris : FR0005175080)
